We demonstrated that LAG-3 bioactivity plays a role in RA, as the addition of rhLAG-3 leads to a decrease in proinflammatory cytokines including TNFα and IFNγ, known to be pivotal for the pathogenesis in RA. The gene discussed is IFNG; the disease is rheumatoid arthritis.